These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 22717235)

  • 1. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis.
    Williams KL; Warraich ST; Yang S; Solski JA; Fernando R; Rouleau GA; Nicholson GA; Blair IP
    Neurobiol Aging; 2012 Oct; 33(10):2527.e3-10. PubMed ID: 22717235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.
    Deng HX; Chen W; Hong ST; Boycott KM; Gorrie GH; Siddique N; Yang Y; Fecto F; Shi Y; Zhai H; Jiang H; Hirano M; Rampersaud E; Jansen GH; Donkervoort S; Bigio EH; Brooks BR; Ajroud K; Sufit RL; Haines JL; Mugnaini E; Pericak-Vance MA; Siddique T
    Nature; 2011 Aug; 477(7363):211-5. PubMed ID: 21857683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice.
    Ceballos-Diaz C; Rosario AM; Park HJ; Chakrabarty P; Sacino A; Cruz PE; Siemienski Z; Lara N; Moran C; Ravelo N; Golde TE; McFarland NR
    Mol Neurodegener; 2015 Jul; 10():25. PubMed ID: 26152284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis.
    Millecamps S; Corcia P; Cazeneuve C; Boillée S; Seilhean D; Danel-Brunaud V; Vandenberghe N; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Meininger V; LeGuern E; Salachas F
    Neurobiol Aging; 2012 Apr; 33(4):839.e1-3. PubMed ID: 22169395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Thumbadoo KM; Dieriks BV; Murray HC; Swanson MEV; Yoo JH; Mehrabi NF; Turner C; Dragunow M; Faull RLM; Curtis MA; Siddique T; Shaw CE; Newell KL; Henden L; Williams KL; Nicholson GA; Scotter EL
    Brain; 2024 Oct; 147(10):3547-3561. PubMed ID: 38703371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis.
    Osaka M; Ito D; Yagi T; Nihei Y; Suzuki N
    Hum Mol Genet; 2015 Mar; 24(6):1617-29. PubMed ID: 25398946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis.
    Teyssou E; Chartier L; Amador MD; Lam R; Lautrette G; Nicol M; Machat S; Da Barroca S; Moigneu C; Mairey M; Larmonier T; Saker S; Dussert C; Forlani S; Fontaine B; Seilhean D; Bohl D; Boillée S; Meininger V; Couratier P; Salachas F; Stevanin G; Millecamps S
    Neurobiol Aging; 2017 Oct; 58():239.e11-239.e20. PubMed ID: 28716533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
    Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
    Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation.
    Alexander EJ; Ghanbari Niaki A; Zhang T; Sarkar J; Liu Y; Nirujogi RS; Pandey A; Myong S; Wang J
    Proc Natl Acad Sci U S A; 2018 Dec; 115(49):E11485-E11494. PubMed ID: 30442662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2.
    Osaka M; Ito D; Suzuki N
    Biochem Biophys Res Commun; 2016 Apr; 472(2):324-31. PubMed ID: 26944018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in Ireland.
    McLaughlin RL; Kenna KP; Vajda A; Byrne S; Bradley DG; Hardiman O
    Neurobiol Aging; 2014 Jan; 35(1):267.e9-11. PubMed ID: 23973441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1.
    Gilpin KM; Chang L; Monteiro MJ
    Hum Mol Genet; 2015 May; 24(9):2565-77. PubMed ID: 25616961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS.
    Kim SH; Stiles SG; Feichtmeier JM; Ramesh N; Zhan L; Scalf MA; Smith LM; Pandey UB; Tibbetts RS
    Hum Mol Genet; 2018 Jan; 27(2):322-337. PubMed ID: 29161404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
    Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype.
    Synofzik M; Maetzler W; Grehl T; Prudlo J; Vom Hagen JM; Haack T; Rebassoo P; Munz M; Schöls L; Biskup S
    Neurobiol Aging; 2012 Dec; 33(12):2949.e13-7. PubMed ID: 22892309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia.
    Gellera C; Tiloca C; Del Bo R; Corrado L; Pensato V; Agostini J; Cereda C; Ratti A; Castellotti B; Corti S; Bagarotti A; Cagnin A; Milani P; Gabelli C; Riboldi G; Mazzini L; Sorarù G; D'Alfonso S; Taroni F; Comi GP; Ticozzi N; Silani V;
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):183-7. PubMed ID: 23138764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations.
    Le NT; Chang L; Kovlyagina I; Georgiou P; Safren N; Braunstein KE; Kvarta MD; Van Dyke AM; LeGates TA; Philips T; Morrison BM; Thompson SM; Puche AC; Gould TD; Rothstein JD; Wong PC; Monteiro MJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7580-E7589. PubMed ID: 27834214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
    Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
    J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia.
    Fecto F; Siddique T
    J Mol Neurosci; 2011 Nov; 45(3):663-75. PubMed ID: 21901496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.
    Renaud L; Picher-Martel V; Codron P; Julien JP
    Acta Neuropathol Commun; 2019 Jul; 7(1):103. PubMed ID: 31319884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.